CCM
REPL icon

Coldstream Capital Management’s Replimune Group REPL Stock Holding History

Coldstream Capital Management’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-397
Closed -$3.87K – 2834
2025
Q1 		$3.87K Buy
+397
New +$4.91K ﹤0.01% 2799

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Coldstream Capital Management's REPL Position: Q2 2025 in Review

Coldstream Capital Management sold out of Replimune Group (REPL) in Q2 2025, closing a stake of 397 shares — an estimated $3.87K sold.

Coldstream Capital Management first reported a position in REPL in Q1 2025 and held it in 1 quarter. The position peaked at $3.87K in Q1 2025. 174 funds tracked by Wall St. Rank hold REPL as of Q2 2025.

  • Coldstream Capital Management reported no remaining Replimune Group position as of Q2 2025 after selling out during the quarter.
  • Coldstream Capital Management sold 397 Replimune Group shares in Q2 2025, an estimated $3.87K.
  • Coldstream Capital Management first reported a position in Replimune Group in Q1 2025 and held it in 1 quarter.
  • Coldstream Capital Management's Replimune Group position peaked at $3.87K in Q1 2025.
  • 174 funds tracked by Wall St. Rank held Replimune Group as of Q2 2025.

Based on Coldstream Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.